ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
208.56
-5.73 (-2.67%)
At close: Jul 30, 2026, 4:00 PM EDT
209.15
+0.59 (0.28%)
Pre-market: Jul 31, 2026, 4:02 AM EDT
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$554,889
Profits / Employee
$152,261
Market Cap
30.08B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | 7,770 | 530 | 7.32% |
| Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
| Jun 30, 2018 | 5,940 | -140 | -2.30% |
| Jun 30, 2017 | 6,080 | 830 | 15.81% |
| Jun 30, 2016 | 5,250 | 910 | 20.97% |
| Jun 30, 2015 | 4,340 | 240 | 5.85% |
| Jun 30, 2014 | 4,100 | 200 | 5.13% |
| Jun 30, 2013 | 3,900 | 200 | 5.41% |
| Jun 30, 2012 | 3,700 | 250 | 7.25% |
| Jun 30, 2011 | 3,450 | 250 | 7.81% |
| Jun 30, 2010 | 3,200 | 300 | 10.34% |
| Jun 30, 2009 | 2,900 | 200 | 7.41% |
| Jun 30, 2008 | 2,700 | 0 | - |
| Jun 30, 2007 | 2,700 | 200 | 8.00% |
| Jun 30, 2006 | 2,500 | 573 | 29.74% |
| Jun 30, 2005 | 1,927 | 407 | 26.78% |
| Jun 30, 2004 | 1,520 | 56 | 3.83% |
| Jun 30, 2003 | 1,464 | 214 | 17.12% |
| Jun 30, 2002 | 1,250 | 297 | 31.16% |
| Jun 30, 2001 | 953 | 348 | 57.52% |
| Jun 30, 2000 | 605 | 104 | 20.76% |
| Jun 30, 1999 | 501 | 111 | 28.46% |
| Jun 30, 1998 | 390 | 106 | 37.32% |
| Jun 30, 1997 | 284 | 55 | 24.02% |
| Jun 30, 1996 | 229 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Becton, Dickinson and Company | 72,000 |
| Medline | 45,000 |
| Baxter International | 37,500 |
| Alcon | 25,942 |
| Solventum | 20,584 |
| Align Technology | 20,290 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
RMD News
- 9 days ago - BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD) - PRNewsWire
- 15 days ago - ResMed downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 15 days ago - ResMed price target lowered to $220 from $235 at Mizuho - TheFly
- 18 days ago - ResMed downgraded to Neutral from Buy at Citi - TheFly
- 20 days ago - ResMed price target lowered to $225 from $240 at Jefferies - TheFly
- 22 days ago - ResMed price target lowered to $276 from $321 at RBC Capital - TheFly
- 23 days ago - ResMed price target lowered to $225 from $227 at Wells Fargo - TheFly
- 23 days ago - ResMed to sell software business MatrixCare for $490 million - Reuters